These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2845442)

  • 1. Inhibition of the binding and the behavioral effects of thyrotropin-releasing hormone (TRH) by the triazolobenzodiazepines.
    Kozlowski MR
    Pharmacol Biochem Behav; 1988 May; 30(1):73-5. PubMed ID: 2845442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atipamezole, benzodiazepines, bicucullin and tifluadom antagonize the effect of TRH on rat duodenum and displace it from brain and anterior pituitary receptors.
    Järvinen A
    Pharmacol Toxicol; 1991 May; 68(5):371-9. PubMed ID: 1658766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary thyrotropin-releasing hormone receptors: local anesthetic effects on binding and responses.
    Phillips WJ; Enyeart JJ; Hinkle PM
    Mol Endocrinol; 1989 Sep; 3(9):1345-51. PubMed ID: 2558307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of benzodiazepines with thyrotropin-releasing hormone receptors on clonal pituitary cells.
    Joels LA; Drummond AH
    Br J Pharmacol; 1989 Feb; 96(2):450-6. PubMed ID: 2538195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by triazolobenzodiazepines.
    Obata T; Yamamura HI
    Life Sci; 1988; 42(6):659-65. PubMed ID: 2893237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of receptors for thyrotropin-releasing hormone by benzodiazepines: brain regional differences.
    Sharif NA; Burt DR
    J Neurochem; 1984 Sep; 43(3):742-6. PubMed ID: 6146660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.
    Miller LG; Greenblatt DJ; Barnhill JG; Deutsch SI; Shader RI; Paul SM
    J Neurochem; 1987 Nov; 49(5):1595-601. PubMed ID: 2889803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries.
    Roussel JP; Astier H; Tapia-Arancibia L
    Endocrinology; 1986 Dec; 119(6):2519-26. PubMed ID: 3023014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA
    Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN; Gulati A
    Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.
    File SE; Pellow S
    Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of receptor antagonist in elucidating the mechanism of action of TRH in GH3 cells.
    Drummond AH; Hughes PJ; Ruiz-Larrea F; Joels LA
    Ann N Y Acad Sci; 1989; 553():197-204. PubMed ID: 2566295
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone.
    Hawkins EF; Wade R; Engel WK
    J Neurochem; 1987 Jul; 49(1):239-45. PubMed ID: 3035097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors.
    Perlman JH; Nussenzveig DR; Osman R; Gershengorn MC
    J Biol Chem; 1992 Dec; 267(34):24413-7. PubMed ID: 1332958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.
    Chesney CM; Pifer DD; Cagen LM
    Biochem Biophys Res Commun; 1987 Apr; 144(1):359-66. PubMed ID: 3579913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepines modulate voltage-sensitive calcium channels in GH3 pituitary cells at sites distinct from thyrotropin-releasing hormone receptors.
    Gershengorn MC; Thaw CN; Geras-Raaka E
    Endocrinology; 1988 Jul; 123(1):541-4. PubMed ID: 2454810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.